Department of Neurosurgery, Johns Hopkins University, Neuro-Oncology Outcomes Laboratory, Baltimore, Maryland, USA.
Department of Neurosurgery, Johns Hopkins University, Neuro-Oncology Outcomes Laboratory, Baltimore, Maryland, USA.
World Neurosurg. 2014 Jul-Aug;82(1-2):e267-75. doi: 10.1016/j.wneu.2013.08.031. Epub 2013 Sep 25.
The management of patients with brain metastases is typically dependent on their prognosis. Recursive partitioning analysis (RPA) is the most commonly used method for prognosticating survival, but has limitations for patients in the intermediate class. The aims of this study were to ascertain preoperative risk factors associated with survival, develop a preoperative prognostic grading system, and evaluate the utility of this system in predicting survival for RPA class 2 patients.
Adult patient who underwent intracranial metastatic tumor surgery at an academic tertiary care institution from 1997 to 2011 were retrospectively reviewed. Multivariate proportional hazards regression analysis was used to identify preoperative factors associated with survival. The identified associations were then used to develop a grading system. Survival as a function of time was plotted using the Kaplan-Meier method, and survival rates were compared using log-rank analyses.
A total of 421 (59%) of 708 patients were RPA class 2. The preoperative factors found to be associated with poorer survival were: male gender (P < 0.0001), motor deficit (P = 0.0007), cognitive deficit (P = 0.0004), nonsolitary metastases (P = 0.002), and tumor size >2 cm (P = 0.003). Patients having 0-1, 2, and 3-5 of these variables were assigned a preoperative grade of A, B, and C, respectively. Patients with a preoperative grade of A, B, and C had a median survival of 17.0, 10.3, and 7.3 months, respectively. These grades had distinct survival times (P < 0.05).
The present study devised a preoperative grading system that may provide prognostic information for RPA class 2 patients, which may also guide medical and surgical therapies before any intervention is pursued.
脑转移瘤患者的治疗管理通常取决于其预后。递归分区分析(RPA)是目前预测生存率最常用的方法,但对于中等风险类别的患者存在局限性。本研究旨在确定与生存相关的术前危险因素,建立一种术前预后分级系统,并评估该系统在预测 RPA 2 类患者生存中的作用。
回顾性分析 1997 年至 2011 年在一家学术性三级医疗机构接受颅内转移性肿瘤手术的成年患者。采用多变量比例风险回归分析确定与生存相关的术前因素。然后利用这些关联因素建立一个分级系统。采用 Kaplan-Meier 法绘制生存时间函数,并用对数秩检验比较生存率。
在 708 例患者中,有 421 例(59%)为 RPA 2 类。与生存率较差相关的术前因素包括:男性(P < 0.0001)、运动障碍(P = 0.0007)、认知障碍(P = 0.0004)、非孤立性转移(P = 0.002)和肿瘤直径 >2cm(P = 0.003)。有 0-1、2 和 3-5 个这些变量的患者分别被分配术前 A、B 和 C 级。术前分级为 A、B 和 C 的患者的中位生存时间分别为 17.0、10.3 和 7.3 个月。这些分级具有明显的生存时间差异(P < 0.05)。
本研究制定了一种术前分级系统,可为 RPA 2 类患者提供预后信息,也可在进行任何干预之前指导医疗和手术治疗。